MAPT and Alzheimer disease: These trends were reflected in the recent creation of the National Institute of Aging–Alzheimer’s Association (NIA-AA) “ATN” Research Framework [3], which defines AD as a biological construct by the presence of Aβ deposition (A), tau deposition (T), and neurodegeneration (N; as evidenced by atrophy on magnetic resonance imaging).